Alterity Therapeutics Limited

ATH

Alterity Therapeutics Ltd. engages in the research and development into Parkinsonian and other neurodegenerative disorders. The company is headquartered in Melbourne, Victoria and currently employs 12 full-time employees. The company went IPO on 2000-03-28. The firm is focused on developing disease modifying treatments for neurodegenerative diseases. The Company’s lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. The company has the potential to treat Parkinson’s disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The firm also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase 2 clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.

Aneka Tambang (Persero) Tbk (Pt)

ATM

PT Aneka Tambang Tbk engages in the exploration, exploitation, processing, refining, and marketing of minerals, precious metals, and coal. The company is headquartered in Jakarta Selatan, Dki Jakarta and currently employs 4,013 full-time employees. The firm is engaged in the exploration, exploitation, processing, refining and marketing of nickel ore, ferronickel, gold, silver, bauxite, coal and other precious metals. The company operates in three segments, which comprised of nickel, gold and refinery, and bauxite and alumina. Its gold & precious metal refining business segment consists of gold commodity, silver and precious metals processing and refinery services. The gold ore mining is produced from two mining sites: Pongkor, West Java and Cibaliung, Banten. Bauxite contains alumina (AI203) and a mixture of silica, various iron oxides, and titanium dioxide. The company is produced in Tayan Bauxite Mining, West Kalimantan. Its nickel operating segment is comprised of ferronickel and nickel ore sales. Its ferronickel production is operated from the Company’s Southeast Sulawesi Nickel Mining Business Unit.

Altech Batteries Ltd

ATC

Altech Batteries Ltd. is a specialty battery technology company, which engages in commercializing a 100 MWh solid state sodium alumina battery production facility and developing battery materials for a Lithium-ion battery. The company is headquartered in Subiaco, Western Australia and currently employs 11 full-time employees. The company went IPO on 2010-01-27. The firm is engaged in the development of a 10,000 tons per annum (tpa) silicon graphite anode plant in the state of Saxony, Germany, using its alumina coating technology. The battery technology uses table salt and is lithium-free; cobalt-free; graphite-free; and copper-free. The Company’s principal activities include the establishment of a research and development laboratory in Perth, Western Australia as a facility for the further development of its methods for the alumina coating of graphite and silicon particles, typical of those used within the anode of a lithium-ion battery. The company has a joint venture agreement to commercialize the CERENERGY Sodium Alumina Solid State (SAS) Battery. The firm is also focused on construction and operation of a 4,500 tpa high purity alumina (HPA) processing plant at Johor, Malaysia.